Virginia Tech® home

Why Measure?

Insert your title here

Christopher S. Hourigan DM DPhil FRCP

Christopher S. Hourigan, DM, DPhil, FRCP

Professor and Director
Cancer Research Center — D.C.
Fralin Biomedical Research Institute
Maury Strauss Distinguished Public Lecture

Why Measure?

Date: Sept. 17, 2026

Time: 5:30 - 6:30 p.m.  (Reception and hors d'oeuvres at 5 p.m.)

In-person: Room M203, 2 Riverside Circle, Fralin Biomedical Research Institute at VTC

Virtual: Join via Zoom

About this Seminar

Professor Hourigan trained first as a Ph.D. scientist and later became a practicing oncologist, and so knows from both sides how often findings from the research laboratory fail to reach patients with cancer ("bench-to-bedside"). His team works in the opposite direction, developing new tools to study when treatments work and when they do not, asking why the theory so often does not match the reality ("bedside-to-bench"). Their focus is acute myeloid leukemia, an aggressive blood cancer in which most adults enter remission and yet most still die of the disease. By building both ultrasensitive genomic tests and large nationwide collaborations, they have generated practice-changing evidence on what causes recurrence and death after apparently successful treatment - and how best to prevent it.

About Maury Strauss

Maury Strauss was a longtime community benefactor and businessman who supported biomedical research with the goal of energizing the local economy and improving quality of life in our neighborhoods and around the world. In order to ensure the continued success of Roanoke’s biomedical research enterprise, as well as the free public seminars, Mr. Strauss made a generous gift to the series. He passed away in June 2024 at age 99. 

Support Our Research

Your generous support of the Fralin Biomedical Research Institute's rigorous biomedical research enterprise makes a difference for our faculty, students, and patients. Every donation helps accelerate the pace of new discoveries to help patients with cancer, neurological disorders, heart disease, and even rare genetic disorders. Private donations fast-track our progress. 

You May Also Be Interested In...

  • Home Item
    Why Measure?
    Why Measure? , home

    Sept. 17, 2026, 5:30 p.m. (Reception at 5 p.m.) | Christopher S. Hourigan, DM, DPhil, FRCP, Professor and Director, Cancer Research Center — D.C., Fralin Biomedical Research Institute | Maury Strauss Distinguished Public Lecture

  • Home Item
    Brown Adipose Tissue as a Mediator of Cardiovascular Health
    Brown Adipose Tissue as a Mediator of Cardiovascular Health , home

    Sept. 18, 2026, 11:00 a.m. | Kristin Stanford, Ph.D., FAHA, Professor, Department of Surgery; William D. and Jacquelyn L. Wells Chair, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Exercise Medicine Research

  • Home Item
    mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back
    mTor Signaling in Pulmonary Vascular Disease: Bench to Bedside and Back , home

    Sept. 25, 2026, 11:00 a.m. | Elena Goncharova, Ph.D., ATSF, FAHA, Professor, Department of Internal Medicine; Director, Pulmonary Vascular Disease Program, UC Davis School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research

  • Home Item
    How Can Research Inform Better Public Policy Towards Addiction?
    How Can Research Inform Better Public Policy Towards Addiction? , home

    Oct. 2, 2026, 11:00 a.m. | Keith Humphreys, OBE, Ph.D., Esther Ting Memorial Professor, Department of Psychiatry, Stanford University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research

  • Home Item
    Exercise, the Fountain of Youth?
    Exercise, the Fountain of Youth? , home

    Oct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture

  • Home Item
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , home

    Oct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.